• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Symetis

Medtech M&A: The 10 biggest deals so far in 2017

June 29, 2017 By Fink Densford

Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions.  The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11

Filed Under: Blog, Business/Financial News, Mergers & Acquisitions Tagged With: Abbott, becton dickinson, Boston Scientific, C.R. Bard, Cardinal Health, Codman Neuro, Cynosure Inc., Edwards Lifesciences, Hologic, Integra LifeSciences, Johnson and Johnson, Medtronic, Novadaq, stjudemedical, Stryker, Symetis, Teleflex, Valtech Cardio, vascularsolutions

Boston Scientific closes $435m Symetis buyout

May 16, 2017 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it closed its $435 million buyout of Symetis and its line of minimally invasive replacement heart valves. The buyout, announced in March, halted the 2nd run at an initial public offering by Symetis, which launched the IPO March 20 in a bid to raise up to $66 million (€61.5 million) on the Euronext exchange in […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Symetis

Analyst: Boston Scientific could be eyeing a Neovasc buyout

March 31, 2017 By Brad Perriello

Boston Scientific (NYSE:BSX) is a potential acquirer for mitral valve maker Neovasc (NSDQ:NVCN), according to JMP Securities analyst John Gillings, after agreeing to a $435 million deal for aortic valve maker Symetis that doesn’t include its Middle Peak Medical mitral valve assets. Although the all-cash Symetis deal adds the market-ready Acurate transcatheter aortic valve implant to Boston Scientific’s […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Mvalve, neovasc, Symetis

Boston Scientific puts up $435m for Symetis just ahead of IPO

March 30, 2017 By Brad Perriello

Boston Scientific (NYSE:BSX) is putting up $435 million in cash for Symetis and its line of minimally invasive replacement heart valves, the companies said today. The buyout halts the 2nd run at an initial public offering by Symetis, which launched the IPO March 20 in a bid to raise up to $66 million (€61.5 million) on the Euronext exchange in Paris. […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Boston Scientific, Symetis

Symetis acquires mitral valve maker Middle Peak Medical

February 15, 2017 By Brad Perriello

Symetis said yesterday that it acquired Middle Peak Medical, and the transcatheter mitral valve replacement device it’s developing, for an undisclosed amount. Middle Peak, which counts Edwards Lifesciences (NYSE:EW) among its backers, is developing a TMVR device that’s designed to simulate the shape of the posterior leaflet to stop mitral regurgitation. Lausanne, Switzerland-based Symetis said the buyout is […]

Filed Under: Mergers & Acquisitions, Replacement Heart Valves, Wall Street Beat Tagged With: Middle Peak Medical, Symetis

Symetis sets range for $96m IPO

September 15, 2015 By MassDevice

(Reuters) — Symetis, a Swiss maker of replacement heart valve devices, said it has set a price range for its initial sale of shares between 35 and 46 Swiss francs ($36.16-$47.53), as it seeks to raise money from investors for business expansion and R&D. At the midpoint the flotation would fetch CHF 93.2 million ($96.2 million). Symetis […]

Filed Under: Funding Roundup, Initial Public Offering (IPO), Replacement Heart Valves Tagged With: Symetis

TAVI: Symetis battles the big dogs

September 15, 2014 By Arezu Sarvestani Leave a Comment

Symetics battles the big dogs in TAVI

Switzerland-based medical implant maker Symetis is looking to make some major moves in the global transcatheter aortic valve implantation market, and the company’s not afraid to take on some of the medtech industry’s biggest players.

Filed Under: News Well, Replacement Heart Valves Tagged With: Edwards Lifesciences, Symetis

Press Release: Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system

September 12, 2014 By MassDevice Leave a Comment

Press Release: Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system

LAUSANNE, SWITZERLAND – Symetis SA, the leading European developer of transcatheter aortic valve implantation (TAVI) systems, announced today the launch of ACURATE neo, its 15F compatible transfemoral TAVI system. Commercial implantations started early September after Symetis received CE Mark approval for ACURATE neo this summer.

Filed Under: News Well, Regulatory/Compliance, Replacement Heart Valves Tagged With: CE Mark, Press Release, Symetis

TAVI: Symetis chases Medtronic and Edwards with E.U. win for Acurate neo heart valve

September 12, 2014 By Arezu Sarvestani Leave a Comment

TAVI: Symetis chases Medtronic and Edwards with E.U. win for Acurate neo heart valve

Stealthy Swiss device maker Symetis announced today that it’s launching commercial sales of its Acurate neo transfemoral transcatheter aortic valve implantation system, having just won CE Mark approval from European regulators.

Filed Under: News Well, Regulatory/Compliance, Replacement Heart Valves Tagged With: CE Mark, Symetis

Device makers team up for next-gen TAVI system

September 26, 2013 By Arezu Sarvestani Leave a Comment

Device makers team up for next-gen TAVI system

Medical device makers Symetis Inc. and Endoluminal Sciences are reaching across oceans to co-develop a new generation of transcatheter aortic valve implantation systems featuring "active anti-paravalvular leak technology."

The duo entered into a license agreement to incorporate Endoluminal Sciences’ anti-leak system into Symetis’ Acurate TA and Acurate TF product lines, according to a press release.

Filed Under: News Well, Replacement Heart Valves Tagged With: Deals Roundup, Endoluminal Sciences, Symetis

Symetis touts positive findings for its Acurate TA TAVI system

April 4, 2013 By Arezu Sarvestani Leave a Comment

Symetis logo

Swiss medical device maker Symetis released 30-day registry findings for its 2nd-generation transcatheter aortic valve implantation systems, touting high procedural success rates and minimal valve leakage.

Results from the SAVI postmarket registry highlighted findings from the 1st 250 patients implanted with Symetis’ Acurate TA TAVI system, which won European regulatory approval in September 2011.

Filed Under: News Well, Replacement Heart Valves, Research & Development Tagged With: Clinical Trials, Symetis

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS